BrightFocus Alzheimer’s Fast Track 2016

Alzheimer's Fast Track 2016 Group Photo

Co-chairs: Frank M. LaFerla, PhD, Harry M.W. Steinbusch, PhD & Cynthia A. Lemere, PhD

November 9 - 11, 2016
The Dana on Mission Bay
1710 W Mission Bay Drive
San Diego, CA, USA

Graduate students, postdoctoral fellows, or other early-stage scientists focusing on Alzheimer’s disease research, took advantage of this unique opportunity to accelerate their knowledge immersion towards becoming an expert in this exciting field by:

  • Connecting with preeminent Alzheimer’s disease experts and fellow early-stage researchers based in the U.S. and around the world
  • Participating in interactive workgroups and breakout sessions
  • Engaging in scientific debates

Organized by BrightFocus Foundation, Alzheimer’s Fast Track® was a satellite event of the Society for Neuroscience’s annual meeting, which took place in San Diego from November 12 -16, 2016. View and download the flier.

Alzheimer's Disease Fast Track: San Diego, California (November 2016)

Speakers and Topics

“Co-Morbidities and Clinical Manifestations of Alzheimer’s Disease” Session

  • Clinical Manifestations/Vascular Contributions of Alzheimer’s Disease
    Helena Chui, MD, University of Southern California

  • Metabolic Disorders/Insulin Sensitivity Associated with Alzheimer’s Disease
    Suzanne Craft, PhD, Wake Forest University

  • Down’s Syndrome and AD
    Lotta Granholm-Bentley, DDS, PhD, Medical University of South Carolina

  • Neuropathology of Alzheimer’s Disease
    Thomas Montine, MD, PhD, Stanford University

  • Biomarkers of AD: ApoE
    G. William Rebeck, PhD, Georgetown University

  • Imaging of AD
    Michael Yassa, PhD, University of California, Irvine

“Basic Biology and Etiology of Alzheimer’s Disease” Session

  • Conformational Diversity of Amyloid in Alzheimer’s Disease, Including Oligomers
    Charles Glabe, PhD, University of California, Irvine

  • Neuroinflammation and neurodegeneration: How does AD proceed with or without Microglia/Astrocytes?
    Kim Green, PhD, University of California, Irvine

  • Synapses in Alzheimer’s Disease – Why They Dysfunction and Disappear
    William Klein, PhD, Northwestern University

  • Epigenetic Dysregulation in Aging and Alzheimer's Disease
    Harry W.M. Steinbusch, PhD, Maastricht University, The Netherlands

  • Brainstem Dysfunction in Alzheimer’s Disease
    Fred van Leeuwen, PhD, Maastricht University, The Netherlands

“Translating To Therapies for Alzheimer’s Disease” Session

  • Modulating Blood Brain Barrier Permeability with Ultrasound
    Isabelle Aubert, PhD, Sunnybrook Research Institute, University of Toronto

  • From Big Data To Smart Data In Alzheimer’s Disease. Using Predictive Computer Modeling To Translate Basic Research Findings Into Therapeutic Success
    Hugo Geerts, PhD, BachMed, PharmaMBA, Chief Scientific Officer, In Silico Biosciences, Perelman School of Medicine, Univ. of Pennsylvania, Drexel University, Dept. of Pharmacology

  • Challenges of Clinical Trials/Drug Targeting/How Drugs are Evaluated
    Joshua Grill, PhD, University of California, Los Angeles

  • Translational Challenges of Mouse Models in Alzheimer’s Disease
    Frank M. LaFerla, PhD, University of California, Irvine

  • Immune Therapy and Inflammation Reaction in AD/Complement in AD
    Cynthia A. Lemere, PhD, Brigham and Women's Hospital and Harvard Medical School


If you have questions, please send an email to

Workshop Goals

The Alzheimer’s disease research field continues to grow in size and scope. For people entering such a prolific environment, acquiring an initial understanding of the disease becomes more difficult each year. The goal of this workshop is to offer graduate students and postdocs an immersive opportunity to learn and discuss some of the latest trends in Alzheimer’s disease research through close interaction with established leaders in the field.

Workshop sessions emphasize open discussion between students and lecturers, and immediate application of new knowledge. Students will participate in faculty-led exercises such as debate and mock grant proposals.

We hope you agree that this is an important and cost-effective opportunity to build knowledge and professional contacts in the Alzheimer’s disease field. The $400 registration is remarkably discounted and includes all program activities, as well as costs of hotels, meals, and social activities. Registrations are limited, and we encourage early submission.

Coordinating Office:

BrightFocus Foundation

  • Stacy Haller, President and CEO
  • Diane Bovenkamp, PhD, Vice President for Scientific Affairs
  • Kara Summers, Scientific Program Grants Manager
Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.